| Full Name | Avneet Uppal |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 10 W Main St, Woodland, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013574987 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 80386 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Avneet Uppal, 1829 Dunlap Pl, Woodland, CA 95776-5454 Ph: () - | Avneet Uppal, 10 W Main St, Woodland, CA 95695-3016 Ph: (530) 668-8589 |
News Archive
PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH) formerly Modigene Inc., today announced the initiation of a Phase I clinical trial of its long-acting human growth hormone drug candidate hGH-CTP.
Giving birth in an alternative setting within a hospital like a bed-free birthing room or one designed to be "homelike" is just as safe for healthy women as laboring in a traditional hospital bed and women who use these rooms are nearly twice as likely to be satisfied with their birth experiences, according to an updated Cochrane review.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
The UK Centre for Medical Research and Innovation (UKCMRI) has unveiled its vision for the institute, which will be the biggest centre for biomedical research and innovation in Europe.
TARIS Biomedical, a specialty pharmaceutical company pioneering the development of innovative, targeted therapies using drug delivery to treat bladder diseases with high unmet medical need, announced that it has initiated a Phase 1B clinical study in patients with interstitial cystitis (IC). The study will evaluate the safety and tolerability of TARIS' innovative product candidate LiRIS® in patients suffering from moderate-to-severe IC.
› Verified 3 days ago
Cherish Appling, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 W Main St, Woodland, CA 95695 Phone: 530-668-8589 | |
Aneeba Shahzadi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2784 Garrett Pl, Woodland, CA 95776 Phone: 530-668-9047 | |
Sean Alexander Ha, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7 W Main St, Woodland, CA 95695 Phone: 530-666-2448 | |
Steven Bennett, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2185 Bronze Star Dr, T-2408, Woodland, CA 95776 Phone: 530-665-4149 | |
Chuong Duong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1250 E Gibson Rd, Woodland, CA 95776 Phone: 530-665-4309 Fax: 530-665-4310 | |
Muhammad Umair Khalid, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 W Main St, Woodland, CA 95695 Phone: 530-668-8589 |